# This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

> **NCT06817915** · NA · NOT_YET_RECRUITING · sponsor: **Johannes Schiefelbein** · enrollment: 100 (estimated)

## Conditions studied

- Neovascular Age-Related Macular Degeneration (nAMD)

## Interventions

- **BEHAVIORAL:** AI assisted assessment of SD-OCT scans

## Key facts

- **NCT ID:** NCT06817915
- **Lead sponsor:** Johannes Schiefelbein
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817915, "This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06817915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*